106 related articles for article (PubMed ID: 30451788)
21. Identification of key genes involved in the pathogenesis of cutaneous melanoma using bioinformatics analysis.
Chen J; Sun W; Mo N; Chen X; Yang L; Tu S; Zhang S; Liu J
J Int Med Res; 2020 Jan; 48(1):300060519895867. PubMed ID: 31937175
[TBL] [Abstract][Full Text] [Related]
22. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
[TBL] [Abstract][Full Text] [Related]
23. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
[TBL] [Abstract][Full Text] [Related]
24. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
25. High expression of DNA repair pathways is associated with metastasis in melanoma patients.
Kauffmann A; Rosselli F; Lazar V; Winnepenninckx V; Mansuet-Lupo A; Dessen P; van den Oord JJ; Spatz A; Sarasin A
Oncogene; 2008 Jan; 27(5):565-73. PubMed ID: 17891185
[TBL] [Abstract][Full Text] [Related]
26. Melanoma progression, gene expression and DNA microarrays.
Hoek KS
G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
[TBL] [Abstract][Full Text] [Related]
27. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.
Alonso SR; Ortiz P; Pollán M; Pérez-Gómez B; Sánchez L; Acuña MJ; Pajares R; Martínez-Tello FJ; Hortelano CM; Piris MA; Rodríguez-Peralto JL
Am J Pathol; 2004 Jan; 164(1):193-203. PubMed ID: 14695333
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness.
Zhang Z; Zhu S; Yang Y; Ma X; Guo S
Tumour Biol; 2015 Nov; 36(11):8593-600. PubMed ID: 26040769
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of cancer hallmarks in cutaneous melanoma and identification of a novel unfolded protein response as a prognostic signature.
Wan Q; Jin L; Wang Z
Aging (Albany NY); 2020 Oct; 12(20):20684-20701. PubMed ID: 33136551
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
31. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
32. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
[TBL] [Abstract][Full Text] [Related]
33. Review and cross-validation of gene expression signatures and melanoma prognosis.
Schramm SJ; Campain AE; Scolyer RA; Yang YH; Mann GJ
J Invest Dermatol; 2012 Feb; 132(2):274-83. PubMed ID: 21956122
[TBL] [Abstract][Full Text] [Related]
34. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
Sominidi-Damodaran S; Pittelkow MR; Meves A
Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
[No Abstract] [Full Text] [Related]
35. Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
Mirmohammadsadegh A; Baer A; Nambiar S; Bardenheuer W; Hengge UR
Cells Tissues Organs; 2004; 177(3):119-23. PubMed ID: 15388985
[TBL] [Abstract][Full Text] [Related]
36. The prognostic potential of alternative transcript isoforms across human tumors.
Trincado JL; Sebestyén E; Pagés A; Eyras E
Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
[TBL] [Abstract][Full Text] [Related]
37. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
38. Melanoma gene expression and clinical course.
Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B
Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132
[TBL] [Abstract][Full Text] [Related]
39. A multigene support vector machine predictor for metastasis of cutaneous melanoma.
Wei D
Mol Med Rep; 2018 Feb; 17(2):2907-2914. PubMed ID: 29257259
[TBL] [Abstract][Full Text] [Related]
40. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.
Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y
Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
